UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: May 02, 2016
Accession Number: 0001193125-16-569643
Submission Type: POS AM
CIK: 0001505512
Company Name: Regulus Therapeutics Inc.
File Number: 333-203292
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Regulus Therapeutics Charts.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Regulus Therapeutics Charts.